Intravenous Immunoglobulins, Human

DRUG3 trials

Sponsors

Mayo Clinic, First Affiliated Hospital of Wenzhou Medical University, Meyer Children's Hospital IRCCS

Conditions

AnakinraGuillain-Barre SyndromeKawasaki DiseaseStiff-Person Syndrome

Phase 3

Randomized Placebo Controlled Trial of IVIg in Glycine Receptor Antibody Positive Stiff-person Syndrome

WithdrawnNCT03749096

Mayo ClinicStiff-Person Syndrome

Start: 2018-12-07End: 2019-04-26Updated: 2019-06-13

Phase 4

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

First Affiliated Hospital of Wenzhou Medical UniversityGuillain-Barre Syndrome

Start: 2013-01-02End: 2025-01-31Target: 450Updated: 2023-09-18

Non Inferiority KawasakI Trial With Anakinra

Not yet recruitingNCT06697431

Meyer Children's Hospital IRCCSAnakinra, Kawasaki Disease

Start: 2025-04-01End: 2027-04-01Target: 38Updated: 2024-11-21